Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+57.3%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+57.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$32.30M+569.4%
2024$4.83M+10.2%
2023$4.38M-47.3%
2022$8.31M-27.9%
2021$11.53M+5134.1%
2020$-229000.00+11.0%
2019$-257199.00-1167.4%
2018$-20294.00-
2017$0.00-
2016$0.00-